Clinical Trial Update: Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A dose-ranging study of voclosporin ophthalmic solution in dry eye syndrome and keratoconjunctivitis sicca completed Phase 2/Phase 3 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Keratoconjunctivitis Sicca

Drugs mentioned

• voclosporin ophthalmic solution (voclosporin)

Snippet

Sponsor: Aurinia Pharmaceuticals Inc. | Conditions: Dry Eye Syndrome, Keratoconjunctivitis Sicca | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-12-10